Fundraising Fox

EQT Life Sciences

Private equity

Amsterdam · Series A–Late Stage · 11 people tracked

★ Follow+ Add to CRM⤳ Find an introduction
✨ Fox Verdict
Sign up to see your fit
Stage
Series A–Late Stage
Check
$10.8M – $64.8M
HQ
Amsterdam, NL
Instruments
Equity
Founded
1998
AUM
$3.2B

Team · 11 people

from the firm's website
Anne Portwich· Partner
Felice Verduyn-van Weegen· Partner
Fouad Azzam· Partner
Joachim Rothe· Partner
John de Koning· Partner
Mark Wegter· Partner
Martijn Kleijwegt· Partner
René R. Kuijten· Partner, Head of EQT Life Sciences
Rudy Dekeyser· Partner, Head of Health Economic Funds
Vincent G. Brichard· Venture Partner
Merijn Klaassen· CFO and COO

Frequently asked questions

What stage does EQT Life Sciences invest at?
EQT Life Sciences invests at the Series A, Series B, Growth, Late Stage stages.
What is EQT Life Sciences's typical check size?
EQT Life Sciences typically writes checks of $10.8M – $64.8M.
What sectors does EQT Life Sciences focus on?
EQT Life Sciences focuses on Biotech, Healthtech, Medical Devices, Sector Agnostic.
Where is EQT Life Sciences located?
EQT Life Sciences is headquartered in Amsterdam, NL.

Featured in lists

Series A Investors & VC FirmsInvestors & VC Firms in United StatesSeries B Investors & VC FirmsLate Stage Investors & VC FirmsSeries A Investors & VC Firms in United StatesGrowth Investors & VC FirmsHealthtech Investors & VC FirmsBiotech Investors & VC FirmsHealthtech Series A Investors & VC FirmsSeries B Investors & VC Firms in United StatesBiotech Series A Investors & VC FirmsMedical Devices Investors & VC Firms